Compression Is Life In Cardiac Arrest - Quality Study (CILICA-QS)

NCT ID: NCT03140202

Last Updated: 2017-07-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

65 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-04-18

Study Completion Date

2017-10-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Context: Chest compressions quality is known to be essential in cardiopulmonary resuscitation. Despite a known harmful effect of chest compressions interruptions, current guidelines still recommend provider switch every 2 minutes. Feedback impact on chest compressions quality preservation during cardiopulmonary resuscitation remains to be assessed.

Study design: simulated prospective monocentric randomized crossover trial.

Participants and methods: Sixty five professionals rescuers of the pre-hospital care unit of University Hospital of Caen (doctors, nurses and ambulance drivers) are enrolled to performed continuous chest compression on manikin (ResusciAnne®, Laerdal), twice, with and without a feedback device (CPRmeter®). Correct compression score (the main criterion) is defined by reached target of rate, depth and leaning at the same time (recorded continuously).

Hypothesis: Feedback device preserve chest compression quality above the 2 minutes recommended switch over during cardiopulmonary resuscitation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiac Arrest

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

In Guide group, participants have a real time feedback (and record) on chest compression quality performed by means of the visuals informations profided by the feedback device.

In Blind group, participants have a real time record of chest compression quality performed by means of the feedback device without feedback information of the performance.
Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Guide then blind

This group use the CPRmeter visual feedback during cardiopulmonary resuscitation (screen visible) first, then have no access to the CPRmeter visual feedback during cardiopulmonary resuscitation (screen mask).

Group Type EXPERIMENTAL

CPRmeter (feedback device) with feedback

Intervention Type DEVICE

Participants have a real time feedback and record.

CPRmeter (feedback device) without feedback

Intervention Type DEVICE

Participants have a real time record without feedback.

Blind then guide

This group have no access to the CPRmeter visual feedback during cardiopulmonary resuscitation (screen mask) first then use the CPRmeter visual feedback during cardiopulmonary resuscitation (screen visible).

Group Type EXPERIMENTAL

CPRmeter (feedback device) with feedback

Intervention Type DEVICE

Participants have a real time feedback and record.

CPRmeter (feedback device) without feedback

Intervention Type DEVICE

Participants have a real time record without feedback.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

CPRmeter (feedback device) with feedback

Participants have a real time feedback and record.

Intervention Type DEVICE

CPRmeter (feedback device) without feedback

Participants have a real time record without feedback.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Operational staff of University hospital of Caen pre-hospital unit
* Ability in CardioPulmonary Resuscitation

Exclusion Criteria

* medical contraindication
* refusal
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Caen

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Clement BULEON, MD

Role: PRINCIPAL_INVESTIGATOR

Medical Simulation Center Normandie Simulation en Sante

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Hospital of Caen

Caen, Normandy, France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Clement BULEON, MD

Role: CONTACT

+(33)231064736

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Clement BULEON, MD

Role: primary

+(33)231064736

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

A16-D51-VOL.30

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.